69 / 100 SEO Score

Josep Allué Creus | Regulatory Affairs | Best Researcher Award

Prof. Dr. Josep Allué Creus, Apdena Consult, Spain

Prof. Dr. Josep Allué Creus 🧪🌿 is a renowned Doctor of Pharmacy and expert in phytotherapy. A retired Professor of Plant Physiology at the Universitat Autònoma de Barcelona 🎓, he co-directs the Master’s and Postgraduate Programs in Phytotherapy at IL3, University of Barcelona 💻📘. He serves as the spokesperson for Medicinal Plants and Homeopathy at the College of Pharmacists of Barcelona 💊 and is a founding member and treasurer of SEFIT. As part of AEEM’s Natural Products group 👩‍⚕️, his research integrates botanical science and women’s health, making him a leader in herbal medicine 🌸🔬.

Publication Profile

Orcid

Education

Prof. Dr. Josep Allué Creus 🎓🧪 exemplifies academic excellence with a prestigious Doctorate in Pharmacy, laying the cornerstone for his remarkable contributions to the fields of phytotherapy and medicinal plant sciences 🌿📚. His doctoral foundation reflects a deep-rooted dedication to advancing healthcare through botanical knowledge and evidence-based research 🔬💊. Prof. Allué’s commitment to scientific integrity and innovation has positioned him as a respected authority in natural medicine 🌱, influencing both academic circles and clinical applications. His passion for teaching and research continues to inspire the next generation of pharmacists and phytotherapy experts across Spain and beyond 🌍👨‍🏫.

Experience

Prof. Dr. Josep Allué Creus 📘🌿 has made significant academic and teaching contributions as a Professor of Plant Physiology at the Universitat Autònoma de Barcelona 🏛️. Throughout his career, he nurtured and mentored countless students, shaping future generations of scientists, pharmacists, and healthcare professionals 👩‍⚕️🧑‍🔬. His passion for education did not end with retirement—he continues to share his expertise as a co-director of master’s and postgraduate programs in phytotherapy through IL3 at the University of Barcelona 🎓🌱. Prof. Allué’s unwavering dedication to lifelong learning and botanical sciences remains a beacon of inspiration in academic circles 🔬📖.

Research Focus

Prof. Dr. Josep Allué Creus 🧠🌿 focuses on two dynamic research domains: phytotherapy and neurodegenerative diseases. His pioneering work on medicinal plant extracts 🌱, such as hemp-derived compounds, highlights their therapeutic potential for conditions like gastrointestinal disorders and dyspepsia 💊. Parallelly, he contributes extensively to cutting-edge Alzheimer’s research, especially in biomarker development for early detection of cognitive decline 🧬🧪. His publications delve into plasma-based assays for amyloid and tau proteins, advancing non-invasive diagnostics in neurology 🧫🔍. Bridging natural medicine and modern neurobiology, Prof. Allué champions holistic innovation in health science.

Publication Top Notes

Hemp Extract (<i>Extractum Cannabis</i>) in the Treatment of Gastrointestinal Distress and Dyspepsia: Historical Insights from Barcelona, Spain

Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer’s disease in individuals with subjective cognitive decline

Clinical utility of an antibody-free LC-MS method to detect brain amyloid deposition in cognitively unimpaired individuals from the screening visit of the A4 Study

Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity

Detecting amyloid positivity in early Alzheimer’s disease using combinations of plasma Aβ42/Aβ40 and p-tau

Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease

Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations

Performance of the plasma Aβ42/Aβ40 ratio, measured with a novel HPLC-MS/MS method, as a biomarker of amyloid PET status in a DPUK-KOREAN cohort

The global Alzheimer’s Association round robin study on plasma amyloid β methods

Plasma amyloid, phosphorylated tau, and neurofilament light for individualized risk prediction in mild cognitive impairment

Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer’s Disease

Josep Allué Creus | Regulatory Affairs | Best Researcher Award

You May Also Like